Organon & Co. (OGN) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

question during this time, please press star 1 on your telephone keypad. I would now like to turn the conference over to Jennifer Halchuk, Vice President Investor Relations. You may begin. Thank you, operator, and good morning, everyone. Thank you for joining Organon's second quarter earnings call. With me today are Kevin Ali, Organon's Chief Executive Officer, and Matt Walsh, our Chief Financial Officer. Juan Camilo Arjona-Ferreira, Organon's Head of R&D, will also be joining for the Q&A portion of this call. Today we will be referencing a presentation that will be visible during this call for those of you on our webcast. This presentation will also be available following this call on the events and presentation section of our Organon Investor Relations website at .organon.com. Before we begin, I would like to caution listeners that certain information discussed by management during this conference call will include forward-looking statements. Actual results could differ materially from those stated or implied by forward-looking statements due to risks and uncertainties associated with the company's business, which are discussed in the company's filings with the Securities and Exchange Commission, including their 10K and subsequent periodic filings. In addition, we will discuss certain non-GAP financial measures on this call, which should be considered a supplement to and not a substitute for financial measures prepared in accordance with GAP. A reconciliation of these non-GAP measures to the comparable GAP measures is included in the press release and conference call presentation. I would now like to turn the call over to our CEO, Kevin Ali. Good morning, everyone, and thank you, Jen. Revenue for the second quarter was $1.6 billion, down 1% at constant currency, wi...